Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Construction in Progress (2022 - 2024)

Updated

Impact Biomedical's Construction in Progress was $263,000 in Q3 2024, unchanged from $263,000 a year earlier and unchanged from the prior quarter.

Analysis

Impact Biomedical (IBO) Construction in Progress (2022 - 2024) Analysis & Trends

From Q4 2022 onward, Impact Biomedical has reported Construction in Progress for 7 quarters.

  • In earlier years, Construction in Progress was $251,000 in FY2022.
  • Per Business Quant data, IBO's Construction in Progress in the three quarters before Q3 2024 was $263,000 (Q2 2024), $263,000 (Q1 2024) and $263,000 (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 263,000.00
Jun 30, 2024 263,000.00
Mar 31, 2024 263,000.00
Dec 31, 2023 263,000.00
Sep 30, 2023 263,000.00
Jun 30, 2023 263,000.00
Dec 31, 2022 251,000.00
API Access

Impact Biomedical Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=IBO&period=max&api_key=YOUR_API_KEY